Home Bratislava Medical Journal 2017 Bratislava Medical Journal Vol.118, No.7, p.394-398, 2017

Journal info


 


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.564

 

Aims and Scope
Editorial Info
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.118, No.7, p.394-398, 2017

Title: Roles of adiponectin and leptin as diagnostic markers in pancreatic cancer
Author: M. Kadri Colakoglu, E. B. Bostanci, Y. Ozdemir, T. Dalgic, E. Aksoy, I. Ozer, Y. Ozogul, V. Oter
Abstract: NTRODUCTION:  Obesity is one of the most serious public health problem worldwide. Adipose tissue synthetize and secrete many growth factors and several cytokines known as adipokines. Studies demonstrated changes in the levels of these adipokines in many types of cancer associated with obesity.
In this study, we aimed to evaluate the possible relationship between adiponectin and leptin levels with pancreas cancer and disease stage, representative of Turkish population.
MATERIALS AND METHODS:  The study was conducted between April 2012 – November 2013. Study included 46 patients – 46 control subjects, who had pancreatic carcinoma. Results between the patients and the control group and relationship between the disease stage and results were evaluated.
RESULTS:  The comparison of preoperative adiponectin and leptin levels of the study group with the levels of the control group showed that there was no correlation with adiponectin and pancreas cancer. In contrast, leptin levels in the study group were significantly lower than in the control group. There was no correlation between the disease stage and adiponectin and leptin levels.
CONCLUSION:  There was a significant correlation between low leptin levels and pancreatic cancer, while adiponectin had no correlation. Differential diagnosis of pancreas cancer can be made by evaluating low leptin levels with elevated tumor markers (Tab. 3, Ref. 17).
Keywords:
Published online: 24-Jul-2017
Year: 2017, Volume: 118, Issue: 7 Page From: 394, Page To: 398
doi:10.4149/BLL_2017_077


download file


© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.